Search Results - "Siddiqui, Maqsood Ahmad"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies

    Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies by Hussain, Afzal, AlAjmi, Mohamed Fahad, Rehman, Md. Tabish, Amir, Samira, Husain, Fohad Mabood, Alsalme, Ali, Siddiqui, Maqsood Ahmad, AlKhedhairy, Abdulaziz A., Khan, Rais Ahmad

    Published in Scientific reports (27-03-2019)
    “…Copper-based compounds are promising entities for target-specific next-generation anticancer and NSAIDS therapeutics. In lieu of this, benzimidazole scaffold…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH₂, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia

    Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH₂, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia by Rajput, Satyendra Kumar, Siddiqui, Maqsood Ahmad, Kumar, Vivek, Meena, Chhuttan Lal, Pant, Aditya Bhushan, Jain, Rahul, Sharma, Shyam Sunder

    Published in Peptides (New York, N.Y. : 1980) (01-06-2011)
    “…In the present study, the newly synthesized TRH analog (l-pGlu-(2-propyl)-l-His-l-ProNH₂; NP-647) was evaluated for its effects in in vitro (oxygen glucose…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells

    Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells by Yousuf, Imtiyaz, Arjmand, Farukh, Tabassum, Sartaj, Toupet, Loic, Khan, Rais Ahmad, Siddiqui, Maqsood Ahmad

    “…A new chromone-appended Cu(ii) drug entity () was designed and synthesized as a potential anticancer chemotherapeutic agent. The structural elucidation was…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  4. 4
    Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH sub(2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia)

    Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH sub(2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia) by Rajput, Satyendra Kumar, Siddiqui, Maqsood Ahmad, Kumar, Vivek, Meena, Chhuttan Lal, Pant, Aditya Bhushan, Jain, Rahul, Sharma, Shyam Sunder

    Published in Peptides (New York, N.Y. : 1980) (01-06-2011)
    “…In the present study, the newly synthesized TRH analog (l-pGlu-(2-propyl)-l-His-l-ProNH sub(2; NP-647) was evaluated for its effects in in vitro (oxygen…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Protective effects of l-pGlu-(2-propyl)- l-His- l-ProNH 2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia

    Protective effects of l-pGlu-(2-propyl)- l-His- l-ProNH 2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia by Rajput, Satyendra Kumar, Siddiqui, Maqsood Ahmad, Kumar, Vivek, Meena, Chhuttan Lal, Pant, Aditya Bhushan, Jain, Rahul, Sharma, Shyam Sunder

    Published in Peptides (New York, N.Y. : 1980) (2011)
    “…► In this study, we have investigated neuroprotective potential of TRH analog NP-647 in cerebral ischemia models. ► NP-647 showed protection against oxygen…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: